BAE-SYSTEMS
10.12.2020 15:02:11 CET | Business Wire | Press release
BAE Systems, a world leader in electric propulsion , has delivered the first plug-in capable electric hybrid propulsion systems to Alexander Dennis Limited who are supplying new buses to Ireland. The Series-ER (Electric Range) systems will power Ireland’s fleet of up to 600 Enviro400ER hybrid buses. BAE Systems has supplied systems for the first 100 buses and will supply an additional 180 systems for buses next year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201210005589/en/
The Series-ER system builds on the company’s more than 20 years of innovation and proven technology and powers more than 13,000 buses around the world. That technology is on buses in service throughout Europe, including cities such as Brighton, London, Namur, and Paris. The Irish buses are the first in the world to benefit from the company’s new plug-in technology.
This means that as well as using the efficient onboard generator to charge itself while the bus is on the move, the buses can now also plug into the grid for power, giving operators another way to recharge their buses.
The Series-ER system enables buses to run for up to five kilometers (three miles) at a time with the engine turned off. This capability provides towns and cities with a new opportunity to improve air quality. The buses will use up to 35 percent less fuel when compared to a conventional bus.
“Clean transportation technology in our cities is critical to reach a zero emission future,” said Ian Wilson, director of business development for Power & Propulsion Solutions at BAE Systems. “Our system will help Ireland take the next step towards full electrification and improve the air quality where people live, work and visit.”
“The Alexander Dennis Enviro400ER is ideally suited for flexible operating needs including zero-emission running at air pollution hotspots,” said Paul Davies president and managing director at ADL. “With the ability to externally charge the batteries, the use of on-board power generation can be further reduced. This new generation of double deck buses for Ireland once again demonstrates that with ADL’s focus on innovation, we are building the buses our cities need to solve their transport challenges.”
The bus propulsion system includes a highly efficient electric motor and generator, an enhanced battery, and smart electronic controls to create a clean form of electric drive propulsion for the buses. It allows operators to take advantage of green grid power, and sets them up for full electric operation in the future. Operators can now use the grid for power – much like an all-electric bus – and add more battery capacity to increase their engine off time. In many instances this will mean an entire route can operate on grid power when the necessary charging infrastructure is in place.
BAE Systems develops and services its technology at its facilities in Endicott, New York, and Rochester, UK.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201210005589/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission
KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press release
KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige
HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press release
The first SaaS SuperApp for startups and VCs capitalizes on a $25M round a from Nimbus Capital and a +15% stock surge, unveiling a v3/v4 roadmap that bridges public equity with digital asset liquidity. HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026061293689
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press release
Agricultural innovation leader to contribute with agronomic expertise in building accurate crop health, pest forecasting and heat stress models India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release
The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
